Syneos Health.

Syneos Health, a biopharmaceutical solutions organization, agreed to be bought for $7.1 billion by a consortium composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital. They are paying $43 per share for the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT